AbbVie Inc. v. Mylan Pharmaceuticals Inc.
1:13-cv-01072
Overview
Parties
Defendant
Mylan Laboratories Ltd. Operating Company
Represented By
2 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Mylan Pharmaceuticals Inc. Operating Company
Represented By
13 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Plaintiff
Abbvie Deutschland GMBH & Co. KG Operating Company
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
AbbVie Inc. Operating Company
Represented By
8 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Third Party Defendant
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 6,232,333 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,458,818 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,521,651 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2003003261 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 3,146,396 P | US Continuation / Sibling | View Official Patent → |
AbbVie Inc. v. Aurobindo Pharma Limited
AbbVie Inc. v. Amneal Pharmaceuticals, LLC
AbbVie Inc. v. Mylan Pharmaceuticals Inc.
AbbVie Inc. v. Hetero Labs Limited
AbbVie Inc. v. Aurobindo Pharma Limited
AbbVie Inc. v. Roxane Laboratories Inc.
AbbVie Inc. v. Roxane Laboratories Inc.
Patents Involved
There are 9 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6232333
Pharmaceutical composition
|
Filed: 1997-11-07
Issued: 2001-05-15
|
Expired (Term Ended)
Expires: 2017-11-07
|
|
|
US7141593
Pharmaceutical formulations
|
Filed: 2000-05-22
Issued: 2006-11-28
|
Expired (Term Ended)
Expires: 2020-05-22
|
|
|
US7432294
Pharmaceutical formulations
|
Filed: 2006-10-12
Issued: 2008-10-07
|
Expired (Term Ended)
Expires: 2026-10-12
|
|
|
US7148359
Polymorph of a pharmaceutical
|
Filed: 2005-05-04
Issued: 2006-12-12
|
Expired (Term Ended)
Expires: 2025-05-04
|
|
|
US7364752
Solid dispersion pharamaceutical formulations
|
Filed: 2000-11-10
Issued: 2008-04-29
|
Expired (Term Ended)
+688d PTA
Expires: 2022-09-29
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
48
Dispositive
6
Granted
1
Denied
0
Pending / Review
39
Motions by Category
Key Dispositive Motions & Rulings